Logo image
The economic cost of outpatient marijuana treatment for adolescents: findings from a multi-site field experiment
Journal article   Peer reviewed

The economic cost of outpatient marijuana treatment for adolescents: findings from a multi-site field experiment

Michael T French, M Christopher Roebuck, Michael L Dennis, Guy Diamond, Susan H Godley, Frank Tims, Charles Webb and James M Herrell
Addiction (Abingdon, England), v 97 Suppl 1(s1), pp 84-97
Dec 2002
PMID: 12460131

Abstract

Adolescent Ambulatory Care - economics Child Cognitive Therapy - economics Cost-Benefit Analysis Family Therapy - economics Health Care Costs Humans Marijuana Abuse - economics Marijuana Abuse - therapy Regression Analysis Social Support
Despite recent advances in the economic evaluation of adult substance abuse treatment, information and basic research is lacking on the cost of adolescent substance abuse treatment. The present study conducted an economic cost analysis of several outpatient adolescent treatment approaches. The Cannabis Youth Treatment (CYT) study evaluated five structured treatments for cannabis-using adolescents. One of the approaches was implemented by all of the four geographically and institutionally diverse treatment facilities collaborating in CYT; each of the other four approaches was implemented in two of the sites. Using the Drug Abuse Treatment Cost Analysis Program (DATCAP), the economic cost of each site-specific treatment was determined. The average economic costs of the five types of outpatient treatments ranged from $837 to $3334 per episode, and varied by both direct factors (e.g. hours of treatment, treatment retention) and indirect factors (e.g. cost of living, staff level, case-load variation). These adolescent treatment cost estimates are examined in terms of their calculation, variability by condition, variability by site within condition and comparability with previous DATCAP results from outpatient drug-free programs for adults. Future research will integrate treatment outcomes and costs to complete cost-effectiveness and benefit-cost analyses of the five therapies.

Metrics

8 Record Views
63 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Psychiatry
Substance Abuse
Logo image